Clear All
12482 Matching Results — Export these results
Click column titles once to sort ascending, and twice to sort descending.
NDC-11 (Package) NDC-9 (Product) Generic Name Brand Name Strength SEER*Rx Category Major Class Minor Class Administration Route Package Effective Date Package Discontinuation Date Status
68001-0708-25 68001-0708 Palonosetron Hydrochloride Palonosetron 0.25 mg/5mL Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Intravenous Jul 15, 2026 In Use
00075-8001-20 00075-8001 Docetaxel Taxotere Chemotherapy Antimitotic Agent Taxane Intravenous Dec 22, 2011 Jun 30, 2013 No Longer Used
00078-0109-01 00078-0109 Cyclosporine Sandimmune 50.0 mg/mL Ancillary Therapy Immunomodulator Calcineurin Inhibitor Intravenous Nov 14, 1983 In Use
73657-0020-01 73657-0020 melphalan flufenamide Pepaxto 20.0 mg/50mL, 20.0 mg/50mL Chemotherapy Alkylating Agent Nitrogen Mustard Intravenous Feb 26, 2021 Aug 13, 2022 No Longer Used
50742-0525-07 50742-0525 arsenic trioxide ARSENIC TRIOXIDE 2.0 mg/mL Chemotherapy Miscellaneous Agent PML/RARa Intravenous Jan 27, 2021 In Use
69097-0197-67 69097-0197 Granisetron Hydrochloride Granisetron Hydrochloride 4.0 mg/4mL Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Intravenous Jun 30, 2008 Apr 30, 2020 In Use
67184-0510-01 67184-0510 Oxaliplatin Oxaliplatin 200.0 mg/40mL Chemotherapy Alkylating Agent Platinum Compound Intravenous Jun 7, 2016 In Use
45963-0613-86 45963-0613 Paclitaxel Paclitaxel 6.0 mg/mL Chemotherapy Antimitotic Agent Taxane Intravenous Jun 13, 2018 Mar 31, 2021 No Longer Used
54868-2522-01 54868-2522 Filgrastim Neupogen 300.0 ug/mL Ancillary Therapy Immunostimulant Granulocyte Colony-Stimulating Factor Intravenous Jun 8, 1994 In Use
55150-0270-01 55150-0270 Cyclophosphamide Cyclophosphamide 500.0 mg/2.5mL Chemotherapy Alkylating Agent Nitrogen Mustard Intravenous Aug 25, 2021 In Use
82943-0100-03 82943-0100 Cyclophosphamide CYCLOPHOSPHAMIDE 200.0 mg/mL Chemotherapy Alkylating Agent Nitrogen Mustard Intravenous Jan 1, 2024 In Use
00069-4015-10 00069-4015 Doxorubicin Hydrochloride Doxorubicin Hydrochloride 2.0 mg/mL Chemotherapy Antitumor Antibiotic Anthracycline Intravenous Mar 17, 2014 May 31, 2025 In Use
25021-0201-67 25021-0201 Mesna Mesna 100.0 mg/mL Ancillary Therapy Chemoprotective Detoxifying Agent Intravenous Apr 30, 2013 Sep 30, 2016 In Use
82959-0111-01 82959-0111 imetelstat sodium RYTELO 188.0 mg/1 Chemotherapy Enzyme Inhibitor Telomerase Intravenous Jun 6, 2024 In Use
68001-0350-68 68001-0350 GEMCITABINE GEMCITABINE 100.0 mg/mL Chemotherapy Antimetabolite Pyrimidine Analog Intravenous May 25, 2018 May 26, 2018 In Use
63459-0600-10 63459-0600 Arsenic Trioxide Trisenox 1.0 mg/mL Chemotherapy Miscellaneous Agent PML/RARa Intravenous Oct 15, 2000 Aug 15, 2021 No Longer Used
68001-0524-31 68001-0524 Fluorouracil Fluorouracil 50.0 mg/mL Chemotherapy Antimetabolite Pyrimidine Analog Intravenous Feb 18, 2022 In Use
42658-0021-01 42658-0021 Daunorubicin hydrochloride Daunorubicin Hydrochloride 5.0 mg/mL Chemotherapy Antitumor Antibiotic Anthracycline Intravenous Jan 20, 2020 In Use
00703-5656-91 00703-5656 Etoposide Toposar 20.0 mg/mL Chemotherapy Plant Alkaloid Epipodophyllotoxins Intravenous May 16, 2013 Jun 30, 2017 No Longer Used
45963-0613-53 45963-0613 Paclitaxel Paclitaxel 6.0 mg/mL Chemotherapy Antimitotic Agent Taxane Intravenous Jul 19, 2018 Jul 31, 2022 No Longer Used
69339-0228-17 69339-0228 Paclitaxel Paclitaxel 6.0 mg/mL Chemotherapy Antimitotic Agent Taxane Intravenous Nov 7, 2024 In Use
61703-0342-09 61703-0342 Paclitaxel Paclitaxel 6.0 mg/mL Chemotherapy Antimitotic Agent Taxane Intravenous Mar 1, 2004 In Use
50742-0463-16 50742-0463 Docetaxel Anhydrous Docetaxel 10.0 mg/mL Chemotherapy Antimitotic Agent Taxane Intravenous Sep 7, 2017 In Use
68083-0193-01 68083-0193 Carboplatin Carboplatin 10.0 mg/mL Chemotherapy Alkylating Agent Platinum Compound Intravenous Feb 20, 2017 In Use
68152-0114-01 68152-0114 levoleucovorin KHAPZORY 300.0 mg/6mL Ancillary Therapy Antiemetic Antidote Intravenous Jan 2, 2019 In Use

Found 12482 results — Export these results